Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, JVN

Iggbo and DNA Diagnostics Center Announce Partnership to Make DNA Testing More Convenient and Efficient


RICHMOND, Va., Dec. 4, 2017 /PRNewswire/ -- Iggbo, a modern care coordination platform, and DNA Diagnostics Center® (DDC®), one of the world's largest private DNA testing companies, have announced a strategic partnership to empower consumers with valuable information contained in their own DNA. Since 1995, DDC has handled over 10 million DNA samples from 168 countries, offering tests for paternity, immigration, and other family relationships; ancestry; health and beauty; forensics, and genetic traits of animals. Leveraging Iggbo's technology, DDC can now digitally dispatch specimen collection specialists to a patient's home, a physician's office, or to Iggbo's network of care locations around the country.

"Iggbo's partnership with DNA Diagnostics Center makes it possible to access their science in the most convenient, user-friendly way possible. Our technology coordinates point of care so that it occurs at the right time and place," said Nuno Valentine, co-founder and CEO of Iggbo.

Since its launch, Iggbo has delivered on-demand specimen collection and other care in locations selected by patients around the country. Iggbo also operates a growing network of brick-and-mortar care locations in over 40 major markets.

This new partnership allows DDC to leverage Iggbo's network of on-demand specialists and its brick-and-mortar network as a way to offer their customers personalized care. In addition, Iggbo's award-winning Procedure Intelligence technology will help improve the efficiency and logistics of every care experience.

"To be an industry leader in genetic testing for over 20 years requires continual improvement. DDC has been the first to adopt leading technology to find ways to improve the quality and efficiency of handling every DNA sample," said Connie Hallquist, CEO of DNA Diagnostics Center. "Our partnership with Iggbo is an example of our relentless pursuit of the best processes for our customers."

About Iggbo

Iggbo is a healthcare technology company that makes personalized medicine possible for everyone. Our award-winning care coordination platform enables healthcare companies to aggregate their healthcare solutions, services, and labor in one place. Using Iggbo's technology, our partners can automate their process for procuring, dispatching, tracking, and paying their labor. Any healthcare organization can digitally manage their own internal workforce on our platform, or they can discover and connect with trusted, high-quality labor groups to complete their services in a range of convenient settings, including mobile, in-office (where permitted), events, or in our brick-and-mortar care locations around the country. Iggbo puts a thousand healthcare solutions at the fingertips of our customers. www.iggbo.com

About DNA Diagnostics Center®

DNA Diagnostics Center (DDC®) is one of the world's largest private DNA testing companies with offices in Fairfield, Ohio and London, England. Since 1995, DDC® has expertly handled over 10 million DNA samples from 168 countries offering tests for paternity, immigration, and other family relationships; ancestry; health and beauty; forensics, and genetic traits of animals. DDC's accredited ISO 17025 laboratory uses state-of-the-art technology, robotics, and bioinformatics to ensure high quality results, and is certified by CLIA, CAP, AABB, NATA, and the Ministry of Justice. www.DNACenter.com

SOURCE Iggbo


These press releases may also interest you

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...

at 17:00
A record 3,618 graduating students and physicians matched to residency training programs in Canada in this year's R-1 Main Residency Match (R-1 match), the Canadian Resident Matching Service (CaRMS) announced today....



News published on and distributed by: